DELCF - /R E P E A T - Delic Partnership with Paradigm Healthcare of Georgia Brings Clinically Relevant Toxicology Testing to Ketamine Treatment for First Time/

Psychedelic Treatment Chain Ketamine Infusion Centers Will Leverage State-of-the-Art Toxicology Testing Solution to Ensure Highest Quality Results Across Locations

VANCOUVER, BC, Sept. 30, 2021 /CNW/ – Delic Holdings Inc. (CSE:DELC)(OTCQB:DELCF)(FRA: 6X0) (“Delic” or the “Company”), the leading psychedelic wellness platform, today announced a first of its kind partnership with Paradigm Healthcare, an independent clinical laboratory located in St. Simons, Georgia, United States, with a focus on high complexity, clinical toxicology, to bring state-of-the-art testing to  Ketamine Infusion Centers LLC (“KIC“). Through the partnership, KIC will have access to Paradigm’s Benchmark UDT™ toxicology solution that uses LC/MS/MS test methods ...